Trials / Recruiting
RecruitingNCT03313687
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK - an International, Observational Registry
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,500 (estimated)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.
Detailed description
There is a focus on interventional therapies, mechanical circulatory support and new cardiovascular therapeutics in patients with cardiogenic shock (CS). The investigators will describe current practice in study sites including concomitant patients with CS. Therefore, the investigators will monitor drug therapies initiated, devices being utilized as well as outcome and side effect of possible interventions
Conditions
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2030-12-31
- Completion
- 2031-12-31
- First posted
- 2017-10-18
- Last updated
- 2021-10-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03313687. Inclusion in this directory is not an endorsement.